Gujarat Themis Biosyn Ltd
BSE:506879
Gujarat Themis Biosyn Ltd
Income from Continuing Operations
Gujarat Themis Biosyn Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Gujarat Themis Biosyn Ltd
BSE:506879
|
Income from Continuing Operations
₹549.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
62%
|
CAGR 10-Years
33%
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Income from Continuing Operations
₹52.3B
|
CAGR 3-Years
25%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Income from Continuing Operations
₹37.4B
|
CAGR 3-Years
19%
|
CAGR 5-Years
24%
|
CAGR 10-Years
10%
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Income from Continuing Operations
₹90B
|
CAGR 3-Years
67%
|
CAGR 5-Years
19%
|
CAGR 10-Years
11%
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Income from Continuing Operations
₹29.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Income from Continuing Operations
₹13.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gujarat Themis Biosyn Ltd's Income from Continuing Operations?
Income from Continuing Operations
549.7m
INR
Based on the financial report for Dec 31, 2023, Gujarat Themis Biosyn Ltd's Income from Continuing Operations amounts to 549.7m INR.
What is Gujarat Themis Biosyn Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
33%
Over the last year, the Income from Continuing Operations growth was -2%. The average annual Income from Continuing Operations growth rates for Gujarat Themis Biosyn Ltd have been 16% over the past three years , 62% over the past five years , and 33% over the past ten years .